NCT01179880

A Study of E6005 in Japanese Patients With Atopic Dermatitis

A Phase 1/2 Study of E6005 in Japanese Patients With Atopic Dermatitis

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Organon and Co · Industry
• Sex: Male
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The safety and pharmacokinetics of topical application with E6005 ointment compared to vehicle will be evaluated in Japanese male patients with atopic dermatitis. Additionally, the efficacy of topical application with E6005 ointment will be explored in Japanese male patients with atopic dermatitis.

Conditions

• Atopic Dermatitis

Interventions

Type	Name	Description
DRUG	E6005	Four Steps of Ointment Application: Step 1: 0.01% of E6005; Step 2: 0.03% of E6005; Step 3: 0.1% of E6005; Step 4: 0.2% of E6005.
DRUG	Placebo	Matching placebo for each step

Timeline

• Start date: 2010-09-01
• Primary completion: 2012-12-01
• Completion: 2012-12-01
• First posted: 2010-08-11
• Last updated: 2025-06-04

Locations

1 site across 1 country: Japan